ELIPOVIMAB
UNII 81YQ2ZPM4D

Substance Identification & Data

This profile provides standardized clinical and technical data for Elipovimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 81YQ2ZPM4D.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2101210-43-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
81YQ2ZPM4D
CAS Registry Number
2101210-43-7
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ELIPOVIMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C171834
National Cancer Institute reference terminology for clinical and research data.
INN ID
10988
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Elipovimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ELIPOVIMAB

Common Names & Synonyms

ELIPOVIMAB [INN]
ELIPOVIMAB [WHO-DD]
IMMUNOGLOBULIN G1, ANTI-(RETROVIRAL ENVELOPE GLYCOPROTEIN GP120ENV) (HUMAN MONOCLONAL GS-9722 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL GS-9722 .LAMBDA.-CHAIN, DIMER

Technical Codes

GS-9722

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus